The effects of MicroRNA transfections on global patterns of gene expression in ovarian cancer cells are functionally coordinated

BMC Medical Genomics

Volumn 5, Issue , 2012, Pages

  Shahab, Shubin W ^a   Matyunina, Lilya V ^a,b   Hill, Christopher G ^a   Wang, Lijuan ^a   Mezencev, Roman ^a   Walker, L Deette ^a,b   McDonald, John F ^a,b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b Ovarian Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MICRORNA; MICRORNA 128; MICRORNA 7; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL ADHESION; CELL CYCLE REGULATION; CELL DIVISION; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INTERACTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OVARY CELL; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL ADHESION; CELL CYCLE; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANSFECTION; UP-REGULATION;

EID: 84864414066     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-5-33     Document Type: Article

References (49)

1. miRNAs in human cancer. Farazi TA, Spitzer JI, Morozov P, Tuschl T, J Pathol 2011 223 2 102 115 10.1002/path.2806 21125669
2. A complex system of small RNAs in the unicellular green alga Chlamydomonas reinhardtii. Zhao T, Li G, Mi S, Li S, Hannon GJ, Wang XJ, Qi Y, Genes Dev 2007 21 10 1190 1203 10.1101/gad.1543507 17470535 (Pubitemid 46789877)
3. Regulation of mRNA translation and stability by microRNAs. Fabian MR, Sonenberg N, Filipowicz W, Annu Rev Biochem 2010 79 351 379 10.1146/annurev- biochem-060308-103103 20533884
4. Mammalian microRNAs predominantly act to decrease target mRNA levels. Guo H, Ingolia NT, Weissman JS, Bartel DP, Nature 2010 466 7308 835 840 10.1038/nature09267 20703300
5. Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. Hendrickson DG, Hogan DJ, McCullough HL, Lyers JW, Herschlag D, Ferrell JE, Brown PO, PLoS Biol 2009 7 11 1000238 Epub 2009 Nov 10 10.1371/journal.pbio.1000238 19901979
6. Switching from repression to activation: microRNAs can up-regulate translation. Vasudevan S, Tong Y, Steitz JA, Science 2007 318 5858 1931 1934 10.1126/science.1149460 18048652
7. MicroRNA-373 induces expression of genes with complementary promoter sequences. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R, Proc Natl Acad Sci U S A 2008 105 5 1608 1613 10.1073/pnas.0707594105 18227514 (Pubitemid 351346562)
8. MicroRNAs in Cancer. Garzon R, Calin GA, Croce CM, Annu Rev Med 2009 60 167 179 10.1146/annurev.med.59.053006.104707 19630570
9. MicroRNAs as oncogenes and tumor suppressors. Chen CZ, N Engl J Med 2005 353 17 1768 1771 10.1056/NEJMp058190 16251533 (Pubitemid 41549888)
10. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Wahid F, Shehzad A, Khan T, Kim YY, Biochim Biophys Acta 2010 1803 11 1231 1243 10.1016/j.bbamcr.2010.06.013 20619301
11. MicroRNA reexpression as differentiation therapy in cancer. Mishra PJ, Merlino G, J Clin Invest 2009 119 8 2119 2123 19620782
12. MicroRNAs-targeting and target prediction. Saito T, Saetrom P, N Biotechnol 2010 27 3 243 249 10.1016/j.nbt.2010.02.016 20219708
13. The impact of microRNAs on protein output. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP, Nature 2008 455 7209 64 71 10.1038/nature07242 18668037
14. Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach. Shahab SW, Matyunina LV, Mezencev R, Walker LD, Bowen NJ, Benigno BB, McDonald JF, PLoS One 2011 6 7 22508 10.1371/journal.pone. 0022508 21811625
15. Chemosensitization of cancer cells by siRNA using targeted nanogel delivery. Dickerson EB, Blackburn WH, Smith MH, Kapa LB, Lyon LA, McDonald JF, BMC Cancer 2010 10 10 10.1186/1471-2407-10-10 20064265
16. Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ, J Biol Chem 2009 284 9 5731 5741 19073608
17. EGFR regulation by microRNA inlung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Weiss GJ, Bemis LT, Nakajima E, Sugita M, Birks DK, Robinson WA, Varella-Garcia M, Bunn PA Jr, Haney J, Helfrich BA, et al. Ann Oncology 2008 19 6 1053 1059 10.1093/annonc/mdn006 (Pubitemid 351796329)
18. Combinatorial microRNA target predictions. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. Nat Genet 2005 37 5 495 500 10.1038/ng1536 15806104 (Pubitemid 40617277)
19. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Lewis BP, Burge CB, Bartel DP, Cell 2005 120 1 15 20 10.1016/j.cell.2004.12.035 15652477 (Pubitemid 40094598)
20. Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Khan AA, Betel D, Miller ML, Sander C, Leslie CS, Marks DS, Nat Biotechnol 2009 27 6 549 555 19465925
21. Cell-type-specific signatures of microRNAs on target mRNA expression. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N, Proc Natl Acad Sci U S A 2006 103 8 2746 2751 10.1073/pnas.0511045103 16477010
22. MicroRNAs indirectly regulate other microRNAs in ovarian cancer cells. Shahab SW, Matyunina LV, Mittal VK, Wang L, Hill CG, Walker LD, McDonald JF, Brit J Med & Med Res 2012 2 2 172 194
23. Genomica http://genomica.weizmann.ac.il/
24. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM, Nature 2005 433 7027 769 773 10.1038/nature03315 15685193 (Pubitemid 40292988)
25. Widespread changes in protein synthesis induced by microRNAs. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N, Nature 2008 455 7209 58 63 10.1038/nature07228 18668040
26. The nucleotide sequence features of the mature microRNA seem to be responsible for the affinity to human Ago2 AND Ago3 proteins. Omel'ianchuk NA, Ponomarenko PM, Ponomarenko MP, Molekuliarnaia biologiia 2011 45 2 366 375 21634124
27. Involvement of NF-kappaB p50/p65 heterodimer in activation of the human pro-interleukin-1beta gene at two subregions of the upstream enhancer element. Goto M, Katayama KI, Shirakawa F, Tanaka I, Cytokine 1999 11 1 16 28 10.1006/cyto.1998.0390 10080875 (Pubitemid 29097348)
28. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Williams TM, Lisanti MP, Am J Physiol Cell Physiol 2005 288 3 494 C506 15692148
29. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. Razani B, Zhang XL, Bitzer M, von Gersdorff G, Bottinger EP, Lisanti MP, J Biol Chem 2001 276 9 6727 6738 10.1074/jbc.M008340200 11102446
30. microRNAs: Master regulators as potential therapeutics in cancer. Garofalo M, Croce CM, Annu Rev Pharmacol Toxicol 2011 51 25 43 10.1146/annurev-pharmtox-010510-100517 20809797
31. MicroRNAs in clinical oncology: at the crossroads between promises and problems. Metias SM, Lianidou E, Yousef GM, J Clin Pathol 2009 62 9 771 776 10.1136/jcp.2009.064717 19734473
32. Cancer microRNAs: From subtype profiling to predictors of response to therapy. Chan E, Prado DE, Weidhaas JB, Trends Mol Med 2011 17 5 235 243 10.1016/j.molmed.2011.01.008 21354374
33. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Chen Y, Zhu X, Zhang X, Liu B, Huang L, Mol Ther 2010 18 9 1650 1656 10.1038/mt.2010.136 20606648
34. Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles. Liu XQ, Song WJ, Sun TM, Zhang PZ, Wang J, Mol Pharm 2011 8 1 250 259 10.1021/mp100315q 21138272
35. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. Shalgi R, Lieber D, Oren M, Pilpel Y, PLoS Comput Biol 2007 3 7 131 10.1371/journal.pcbi.0030131 17630826 (Pubitemid 47196171)
36. Hub genes with positive feedbacks function as master switches in developmental gene regulatory networks. Seo CH, Kim JR, Kim MS, Cho KH, Bioinformatics 2009 25 15 1898 1904 10.1093/bioinformatics/btp316 19439566
37. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Yang J, Weinberg RA, Dev Cell 2008 14 6 818 829 10.1016/j.devcel.2008.05.009 18539112 (Pubitemid 351757205)
38. Hallmarks of cancer: the next generation. Hanahan D, Weinberg RA, Cell 2011 144 5 646 674 10.1016/j.cell.2011.02.013 21376230
39. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. Micallef J, Taccone M, Mukherjee J, Croul S, Busby J, Moran MF, Guha A, Cancer Res 2009 69 19 7548 7556 10.1158/0008-5472.CAN-08-4783 19773446
40. Effect of tissue fixatives on telomere length determination by quantitative PCR. Koppelstaetter C, Jennings P, Hochegger K, Perco P, Ischia R, Karkoszka H, Mayer G, Mech Ageing Dev 2005 126 12 1331 1333 10.1016/j.mad.2005. 08.003 16182339 (Pubitemid 41572251)
41. RTPrimerDB: the real-time PCR primer and probe database. Pattyn F, Speleman F, De Paepe A, Vandesompele J, Nucleic Acids Res 2003 31 1 122 123 10.1093/nar/gkg011 12519963 (Pubitemid 36150349)
42. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Pfaffl MW, Horgan GW, Dempfle L, Nucleic Acids Res 2002 30 9 36 10.1093/nar/30.9.e36 11972351
43. Camalexin induces apoptosis in T-leukemia Jurkat cells by increased concentration of reactive oxygen species and activation of caspase-8 and caspase-9. Mezencev R, Updegrove T, Kutschy P, Repovská M, McDonald J, Journal of Natural Medicines 2011 65 3 488 499 10.1007/s11418-011-0526-x 21424253
44. Peptide-functionalized nanogels for targeted siRNA delivery. Blackburn WH, Dickerson EB, Smith MH, McDonald JF, Lyon LA, Bioconjug Chem 2009 20 5 960 968 10.1021/bc800547c 19341276
45. Bioconductor: open software development for computational biology and bioinformatics. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Genome Biol 2004 5 10 80 10.1186/gb-2004-5-10-r80 15461798
46. Significance analysis of microarrays applied to the ionizing radiation response. Tusher VG, Tibshirani R, Chu G, Proc Natl Acad Sci U S A 2001 98 9 5116 5121 10.1073/pnas.091062498 11309499 (Pubitemid 32397092)
47. Probe set filtering increases correlation between Affymetrix GeneChip and qRT-PCR expression measurements. Mieczkowski J, Tyburczy ME, Dabrowski M, Pokarowski P, BMC Bioinformatics 2010 11 104 10.1186/1471-2105-11-104 20181266
48. The microRNA.org resource: targets and expression. Betel D, Wilson M, Gabow A, Marks DS, Sander C, Nucleic Acids Res 2008 36 Database issue 149 153 18158296
49. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Betel D, Koppal A, Agius P, Sander C, Leslie C, Genome Biol 2010 11 8 90 10.1186/gb-2010-11-8-r90 20799968